Epilepsy – Talk Bio

Praxis Seizure Drug Vormatrigine Shows Strong Efficacy in Phase 2 Trial

3 weeks ago talkbio0Tagged Clinical Research, Epilepsy, focal onset seizures, Praxis Precision Medicines, Radiant heater, Seizures, Sodium Channel Blockers, vormatrigine

Praxis Precision Medicines; vormatrigine; epilepsy; seizures; RADIANT study; focal onset seizures; Phase 2 trial; sodium channel blocker

Praxis touts ‘best-in-disease’ epilepsy data, but shares dip

3 weeks ago talkbio0Tagged anti-seizure medication, Clinical Research, Clinical Trials, Epilepsy, focal onset seizures, Market, Praxis Precision Medicines, Radiant heater, Seizures, vormatrigine

Praxis Precision Medicines; epilepsy; vormatrigine; RADIANT study; focal onset seizures; Phase 2 trial; seizure reduction; clinical trial; anti-seizure medication; stock market

Regeneron Leads $66M Series B for Actio Biosciences’ Rare Disease Therapeutics

2 months ago talkbio0Tagged ABS-0871, ABS-1230, Actio, Biosciences, Charcot-Marie-Tooth Disease, Clinical Trials, Drugs, Orphan, Epilepsy, Infrequent, Inhibitor, KCNT1 gene, Regeneron, Series B financing, TRPV4 protein, human

Regeneron; Actio Biosciences; rare diseases; Series B financing; KCNT1 inhibitor; TRPV4 inhibitor; ABS-1230; ABS-0871; Charcot-Marie-Tooth disease; epilepsy; orphan drug; clinical trials

Neurona nabs $102M to launch pivotal trial of epilepsy cell therapy

5 months ago talkbio0Tagged Cell Therapy, drug-resistant, Epilepsy, Identifier, MTLE, RMAT

MTLE, Epilepsy, Cell Therapy, RMAT, Identifier, drug-resistant

Beyond the Diagnosis: Embracing the Humanity Behind Epilepsy Care

6 months ago talkbio0Tagged Comprehensive, Empowered, Epilepsy, Experience, Holistic epilepsy management, Interdisciplinary Studies, Patient-Centered, Quality of life

Patient-centered epilepsy care, Holistic epilepsy management, Quality of life in epilepsy, Empowering epilepsy patients, Multidisciplinary epilepsy treatment, Epilepsy patient experiences, Comprehensive epilepsy support